TCL Archive In Brief: Reginald Ho Assumes ACS Presidency; Board Calls On NCI To Fully Fund ASSIST Program November 13, 1992
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive DCCP Board Approves Concepts For Nearly $20 Million In Grants, Contracts, Including New Inhibitors Study June 10, 1983
